A Licensing Deal Gone Sideways
Qualcomm built its custom chip ambitions on a foundation it did not fully own. When the company acquired Nuvia in 2021 for $1.4 billion, it was buying a team of elite chip architects who had walked out of Apple with deep knowledge of high-performance ARM-based designs. The plan was straightforward: use Nuvia’s expertise to build Snapdragon processors that could finally challenge Apple Silicon on performance per watt. What Qualcomm did not fully account for was Arm Holdings’ willingness to challenge that plan in court.
Arm sued Qualcomm in 2022, arguing that when Qualcomm acquired Nuvia, it inherited Nuvia’s architectural license but could not simply fold that license into Qualcomm’s own broader licensing agreement. Arm’s position was precise and aggressive: Nuvia’s license should have been terminated upon acquisition, and any chips designed using Nuvia’s architecture required a fresh, separately negotiated license from Arm. The case puts a spotlight on how Arm structures its licensing agreements – and how those agreements can become a strategic tool against the very companies that build on top of them.
What the Nuvia License Fight Is Really About
On the surface, this looks like a contract dispute. Underneath, it is a fight over who controls the economics of custom ARM chip design. Arm licenses its architecture in two main ways: an architecture license, which lets a company design its own custom CPU cores from scratch using the ARM instruction set, and a standard TLA (Technology License Agreement), which covers the use of Arm’s off-the-shelf core designs. Nuvia held an architecture license. Qualcomm holds both types, but its architecture license governs different products under different royalty terms than what Nuvia had negotiated. Arm’s argument is that those terms do not automatically merge when one company acquires another.
If Arm wins – or forces a settlement on its terms – the financial implications for Qualcomm go well beyond legal fees. Qualcomm would potentially owe royalties structured around Nuvia’s original license terms, which Arm could argue apply to every Snapdragon X Elite chip already shipped. That is not a hypothetical liability sitting in the distant future. Snapdragon X Elite chips are already in laptops on retail shelves, and Microsoft’s Copilot+ PC push has made Qualcomm’s ARM laptop chips a centerpiece of its hardware strategy. A renegotiated royalty structure on those chips could quietly erode margins on a product line Qualcomm has spent years building as its PC market entry point.
Arm’s Broader Leverage Play
Arm is not just fighting Qualcomm. It is sending a message to every company that has acquired, merged with, or licensed through another entity that holds an Arm architectural agreement. The company went public in 2023 with a valuation that leaned heavily on the story of rising royalty rates as chips become more complex and more valuable. That story depends on Arm actually enforcing those higher rates – which means it cannot afford to let acquisition-based license transfers become a standard workaround for renegotiation.
The licensing structure Arm uses gives it unusual leverage at critical moments. Because every ARM-based chip, no matter how custom, still needs to be compatible with the ARM instruction set to run software written for that ecosystem, no chip designer can simply walk away from the licensing relationship. RISC-V exists as an alternative, but moving an entire chip architecture to RISC-V is a multi-year engineering undertaking with no guarantee that software ecosystems follow. Qualcomm is not in a position to pivot away from ARM on a product roadmap that extends years forward.
This dynamic makes Arm’s litigation posture unusually strong. Qualcomm needs Arm more than Arm needs any single chip company. Arm’s architecture runs across mobile, PC, data center, and automotive applications – losing Qualcomm as a licensee would hurt Arm’s revenue, but Qualcomm losing access to ARM would effectively end its semiconductor business. That asymmetry is the quiet engine driving Arm’s willingness to litigate rather than settle quietly.
What makes the situation more complicated is that Arm is not simply seeking damages. It asked the court to cancel Qualcomm’s license entirely if Qualcomm does not pay what Arm believes it is owed. That remedy, even if it never actually gets enforced, creates pressure during any settlement negotiation that is very hard to ignore.
Qualcomm’s Position and Its Limits
Qualcomm has argued that its own existing architectural license covers the Nuvia-derived designs, and that Arm approved the acquisition without sufficiently objecting at the time. The company also points to the substantial engineering work its own teams performed on the final chip designs – suggesting that calling the Snapdragon X Elite a “Nuvia chip” misrepresents how much the design evolved after acquisition. These are not frivolous arguments, and the case is genuinely close enough that legal observers have not called it a clear win for either side.
But the longer the litigation runs, the more it shadows Qualcomm’s pitch to PC manufacturers and enterprise buyers. No procurement officer wants to build a product roadmap around a chip whose legal status is under active dispute. That uncertainty alone is a cost, even before any judgment arrives.
The Custom Silicon Gold Rush Has a Ceiling
The appeal of custom ARM chip design has never been higher. Apple’s silicon success sparked a wave of companies – Google with its Tensor chips, Amazon with Graviton, Microsoft with its Cobalt data center processor – all pursuing ARM-based custom silicon as a way to optimize performance and reduce dependency on merchant chip vendors. Each of those companies holds its own ARM license, negotiated directly. But the Qualcomm case shows that even a well-resourced company with existing ARM licenses can find itself in an unexpected legal corner when those licenses interact with acquisitions.
For the broader custom chip ecosystem, the case reinforces Arm’s role as a silent gatekeeper. The company does not manufacture chips. It does not sell finished processors. But it sits at the center of every design decision made by companies that do, and its licensing agreements define the boundaries of what custom silicon is actually allowed to look like. As chip design becomes more valuable and more contested, Arm’s ability to enforce – and renegotiate – those agreements becomes a form of market power that does not show up in transistor counts or benchmark scores.
Qualcomm’s next earnings calls will need to address how this litigation affects its PC chip segment guidance. The company has significant momentum in the Windows-on-ARM space after years of disappointing attempts, and walking back that narrative because of a licensing dispute inherited from an acquisition would be a difficult story to tell investors who paid a premium for the growth angle. The trial was scheduled to begin in late 2024, and depending on how proceedings unfold, any settlement Arm extracts could quietly reset the royalty math on every Snapdragon X chip that ships afterward.
Arm set its IPO price on the expectation that its royalty rates would grow as its chips moved into higher-value markets. Qualcomm’s custom chip push, using Nuvia’s designs, moved directly into that higher-value PC and laptop market. The collision was, in retrospect, almost inevitable – two companies with incompatible ideas about who should capture the margin from that move upmarket.
